Cel Sci Corporation (CVM)

[mikedel]

Risky Business

At this price level you need to maintain caution. The indicators are weak that this will be a successful study. Don't trust Geert with his nonsense indicators of success.

1) The primary endpoint results have been known for over a year. The calculation is simple and not complex as Geert stated. The CRO has likely tipped the CEO.

2) The delay has nothing to do with the efficacy regardless of all the analysis work. Geert controls the funding and therefore the timing of all events.

3) Geert has used delaying strategies in the past. Does anyone remember HGP30? No news has always resulted in many failed studies. A failed study is one that leads to NO follow on activities.

4) The IDMC continuance has nothing to do with primary end point determination. This due to verification and complexity. IDMC primarily looking at safety. Why stop a study if enrollment complete and in monitoring phase.

5) The Phase 2 study was minimal ~32 patients and not verified and/or correctly monitored.

7) No endorsements from any major medical organization or prominent doctors. Many US study sites dropped out of P3.

6) Geert's stock holding are irrelevant and posturing.

7) Company financing deals are coordinated with the hedge funds. Geert has likely involvement.

The sole objective is to keep the company relevant for as long as possible to maintain lofty salaries. This strategy has worked for over 30 years at the expense of the shareholders. 2500:1 reverse split is telling. Not a typo.